AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 33158931 — intervention group
Group type: COMPARATOR
Intervention: Control (no PCOS)
Number of subjects: 0
Study 32708446 — intervention group
Group type: EXPERIMENTAL
Intervention: Donkey milk-derived human milk fortifier (DF)
Number of subjects: 10
Study 32708446 — intervention group
Group type: COMPARATOR
Intervention: Bovine milk-derived fortifier (BF)
Number of subjects: 10
Study 35514746 — intervention group
Group type: EXPERIMENTAL
Intervention: Povidone-iodine 0.5% and glycyrrhizic acid 2.5 mg/ml
Number of subjects: 200
Study 35514746 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 200
Study 35844134 — intervention group
Group type: EXPERIMENTAL
Intervention: Brivaracetam (BRV) monotherapy
Number of subjects: 0
Study 35844134 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 34312485 — intervention group
Group type: EXPERIMENTAL
Intervention: Idiopathic pulmonary fibrosis (IPF) patients
Number of subjects: 42777
Study 34312485 — intervention group
Group type: COMPARATOR
Intervention: General population (control)
Number of subjects: 42777
Study 34225830 — intervention group
Group type: EXPERIMENTAL
Intervention: Anodal tDCS over rIFC combined with cognitive training (20 min, 1 mA)
Number of subjects: 50
Study 34225830 — intervention group
Group type: COMPARATOR
Intervention: Sham tDCS over rIFC combined with cognitive training (20 min, 1 mA)
Number of subjects: 50
Study 35015856 — intervention group
Group type: EXPERIMENTAL
Intervention: standard micronutrient powder (MNP) containing 4.1 mg zinc and 10 mg iron, daily
Number of subjects: 2886
Study 35015856 — intervention group
Group type: EXPERIMENTAL
Intervention: high-zinc (10 mg), low-iron (6 mg) (HiZn LoFe) MNP, daily
Number of subjects: 2886
Study 35015856 — intervention group
Group type: EXPERIMENTAL
Intervention: HiZn (10 mg) LoFe (6 mg)/HiZn (10 mg), no-iron MNPs on alternating days
Number of subjects: 2886
Study 35015856 — intervention group
Group type: EXPERIMENTAL
Intervention: dispersible zinc tablet (10 mg), daily
Number of subjects: 2886
Study 35015856 — intervention group
Group type: EXPERIMENTAL
Intervention: dispersible zinc tablet (10 mg), daily for 2 wk at enrollment and 12 wk
Number of subjects: 2886
Study 35015856 — intervention group
Group type: COMPARATOR
Intervention: placebo powder, daily
Number of subjects: 2886
Study 32026478 — intervention group
Group type: EXPERIMENTAL
Intervention: Nomogram for predicting lung cancer-specific survival (LCSS)
Number of subjects: 988
Study 32026478 — intervention group
Group type: EXPERIMENTAL
Intervention: Risk classification system based on the nomogram
Number of subjects: 988
Study 34649742 — intervention group
Group type: EXPERIMENTAL
Intervention: Early mobilization after trapeziectomy (n = 28)
Number of subjects: 59
Study 34649742 — intervention group
Group type: COMPARATOR
Intervention: Postoperative regimen with rigid orthosis and mobilization after 6 weeks (n = 27)
Number of subjects: 59
Study 32881567 — intervention group
Group type: EXPERIMENTAL
Intervention: Poor targets
Number of subjects: 0
Study 32881567 — intervention group
Group type: EXPERIMENTAL
Intervention: Wealthy targets
Number of subjects: 0
Study 32881567 — intervention group
Group type: EXPERIMENTAL
Intervention: Prosocial behavior of poor targets
Number of subjects: 0
Study 32881567 — intervention group
Group type: EXPERIMENTAL
Intervention: Prosocial behavior of wealthy targets
Number of subjects: 0
Study 32100933 — intervention group
Group type: EXPERIMENTAL
Intervention: Chlorhexidine (CHX) mouthwash
Number of subjects: 75
Study 32100933 — intervention group
Group type: EXPERIMENTAL
Intervention: Hyaluronic acid (HA) mouthwash
Number of subjects: 75
Study 32100933 — intervention group
Group type: EXPERIMENTAL
Intervention: Antioxidant mouthwash
Number of subjects: 75
Study 32100933 — intervention group
Group type: EXPERIMENTAL
Intervention: All mouthwashes
Number of subjects: 75
Study 35306827 — intervention group
Group type: EXPERIMENTAL
Intervention: Deferoxamine
Number of subjects: 291
Study 35306827 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 291
Study 32222326 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical activity intervention including 5 key messages, personalized activity suggestions, and support from a Registered Kinesiologist.
Number of subjects: 0
Study 32222326 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical activity intervention (as above)
Number of subjects: 0
Study 32222326 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified in detail)
Number of subjects: 0
Study 33310174 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 g leucine
Number of subjects: 14
Study 33310174 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 g isoleucine
Number of subjects: 14
Study 33310174 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 14
Study 32453774 — intervention group
Group type: EXPERIMENTAL
Intervention: Guided counseling based on the health belief model and the theory of planned behavior; four counseling sessions.
Number of subjects: 346
Study 32453774 — intervention group
Group type: EXPERIMENTAL
Intervention: Guided counseling; dietary diversity.
Number of subjects: 346
Study 32453774 — intervention group
Group type: EXPERIMENTAL
Intervention: Guided counseling; meal frequency.
Number of subjects: 346
Study 32453774 — intervention group
Group type: COMPARATOR
Intervention: Routine nutrition education (Control);
Number of subjects: 346
Study 33877875 — intervention group
Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study 35776026 — intervention group
Group type: COMPARATOR
Intervention: Disposable cystoscope
Number of subjects: 128
Study 35776026 — intervention group
Group type: EXPERIMENTAL
Intervention: Reusable cystoscope
Number of subjects: 128
Study 33876547 — intervention group
Group type: EXPERIMENTAL
Intervention: Smartphone-controlled patch electro-acupuncture (SCEA)
Number of subjects: 37
Study 33876547 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 37
Study 33876547 — intervention group
Group type: EXPERIMENTAL
Intervention: SCEA
Number of subjects: 37
Study 34161807 — intervention group
Group type: EXPERIMENTAL
Intervention: Home-based mobile device designed to enhance self-care behavior
Number of subjects: 118
Study 34161807 — intervention group
Group type: COMPARATOR
Intervention: Standard care (control group)
Number of subjects: 118
Study 32088254 — intervention group
Group type: EXPERIMENTAL
Intervention: Calculation method with interruption defined as ≥ 1 s
Number of subjects: 200
Study 32088254 — intervention group
Group type: EXPERIMENTAL
Intervention: Calculation method with interruption defined as ≥ 2 s
Number of subjects: 200
Study 32088254 — intervention group
Group type: EXPERIMENTAL
Intervention: Calculation method with interruption defined as ≥ 3 s
Number of subjects: 200
Study 32088254 — intervention group
Group type: EXPERIMENTAL
Intervention: Calculation method #3 excluding top and bottom quartiles
Number of subjects: 200
Study 35123694 — intervention group
Group type: EXPERIMENTAL
Intervention: Trametinib 2 mg once daily
Number of subjects: 260
Study 35123694 — intervention group
Group type: COMPARATOR
Intervention: Standard-of-care (intravenous paclitaxel, pegylated liposomal doxorubicin, topotecan, oral letrozole, or oral tamoxifen)
Number of subjects: 260
Study 34051963 — intervention group
Group type: COMPARATOR
Intervention: Essential oil mouthwash with alcohol (control)
Number of subjects: 11
Study 34051963 — intervention group
Group type: EXPERIMENTAL
Intervention: Essential oil mouthwash without alcohol (test)
Number of subjects: 11
Study 34051963 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (control and test)
Number of subjects: 11
Study 32945733 — intervention group
Group type: EXPERIMENTAL
Intervention: Additional counseling that encouraged a discussion
Number of subjects: 0
Study 32945733 — intervention group
Group type: COMPARATOR
Intervention: Standard informed consent for cesarean birth
Number of subjects: 0
Study 32186047 — intervention group
Group type: EXPERIMENTAL
Intervention: Herb-partitioned moxibustion (HPM)
Number of subjects: 640
Study 32186047 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 640
Study 35466696 — intervention group
Group type: EXPERIMENTAL
Intervention: Powerlifting exercise
Number of subjects: 64
Study 35466696 — intervention group
Group type: COMPARATOR
Intervention: Bodyweight exercise
Number of subjects: 64
Study 34559801 — intervention group
Group type: EXPERIMENTAL
Intervention: Azithromycin (20mg/kg, biannual single-dose)
Number of subjects: 614
Study 34559801 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 614
Study 34559801 — intervention group
Group type: EXPERIMENTAL
Intervention: Azithromycin
Number of subjects: 614
Study 35217193 — intervention group
Group type: EXPERIMENTAL
Intervention: Dance training (DG)
Number of subjects: 30
Study 35217193 — intervention group
Group type: EXPERIMENTAL
Intervention: Balance training (BG)
Number of subjects: 30
Study 35217193 — intervention group
Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 30
Study 32240156 — intervention group
Group type: EXPERIMENTAL
Intervention: PopART intervention (Arm A)
Number of subjects: 193907
Study 32240156 — intervention group
Group type: EXPERIMENTAL
Intervention: PopART intervention (Arm B)
Number of subjects: 193907
Study 32240156 — intervention group
Group type: COMPARATOR
Intervention: Standard-of-care (Arm C)
Number of subjects: 193907
Study 34491646 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture combined with medication
Number of subjects: 120
Study 34491646 — intervention group
Group type: COMPARATOR
Intervention: Western medication (oxiracetam capsules, 2 capsules, 3 times a day)
Number of subjects: 120
Study 36330567 — intervention group
Group type: EXPERIMENTAL
Intervention: Active drug use (sertraline, fluvoxamine, risperidone, fluoxetine)
Number of subjects: 599
Study 36330567 — intervention group
Group type: EXPERIMENTAL
Intervention: Female sex
Number of subjects: 599
Study 36330567 — intervention group
Group type: EXPERIMENTAL
Intervention: Early improvement in CGI-I (score of ≤3 at Week 1)
Number of subjects: 599
Study 33634319 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-iron MNP (5 mg iron)
Number of subjects: 53
Study 33634319 — intervention group
Group type: COMPARATOR
Intervention: Standard MNP (12.5 mg iron)
Number of subjects: 53
Study 32121466 — intervention group
Group type: EXPERIMENTAL
Intervention: Dynamic Artificial Intelligence (AI) model using three different BLE advertising channels to detect human body shadowing and compensate RSSI values.
Number of subjects: 0
Study 35179586 — intervention group
Group type: EXPERIMENTAL
Intervention: Atezolizumab (1200 mg) with capecitabine (850 or 1000 mg/m2) and bevacizumab (7.5 mg/kg)
Number of subjects: 133
Study 35179586 — intervention group
Group type: COMPARATOR
Intervention: Placebo with capecitabine (850 or 1000 mg/m2) and bevacizumab (7.5 mg/kg)
Number of subjects: 133
Study 35179586 — intervention group
Group type: EXPERIMENTAL
Intervention: Atezolizumab (1200 mg) with capecitabine and bevacizumab
Number of subjects: 133
Study 35179586 — intervention group
Group type: COMPARATOR
Intervention: Placebo with capecitabine and bevacizumab
Number of subjects: 133
Study 32437629 — intervention group
Group type: EXPERIMENTAL
Intervention: Alliance Project gatekeeper training
Number of subjects: 0
Study 32437629 — intervention group
Group type: COMPARATOR
Intervention: Control training
Number of subjects: 0
Study 32828570 — intervention group
Group type: EXPERIMENTAL
Intervention: Personalized newsletter
Number of subjects: 120
Study 32828570 — intervention group
Group type: COMPARATOR
Intervention: Standard newsletter
Number of subjects: 120
Study 35405931 — intervention group
Group type: EXPERIMENTAL
Intervention: Co-ingestion of soft broccoli and rice (SR)
Number of subjects: 14
Study 35405931 — intervention group
Group type: EXPERIMENTAL
Intervention: Co-ingestion of hard broccoli and rice (HR)
Number of subjects: 14
Study 35405931 — intervention group
Group type: EXPERIMENTAL
Intervention: Soft broccoli prior to rice (S+R)
Number of subjects: 14
Study 35405931 — intervention group
Group type: EXPERIMENTAL
Intervention: Hard broccoli prior to rice (H+R)
Number of subjects: 14
Study 35405931 — intervention group
Group type: COMPARATOR
Intervention: Rice (R)
Number of subjects: 14
Study 33474798 — intervention group
Group type: EXPERIMENTAL
Intervention: Equivalence probability weighted power prior
Number of subjects: 0
Study 33474798 — intervention group
Group type: COMPARATOR
Intervention: Standard methods (modified power prior, commensurate prior, robust mixture prior)
Number of subjects: 0
Study 34949156 — intervention group
Group type: EXPERIMENTAL
Intervention: Treatment as usual with systematic client feedback (SCF) based on the Partners for Change Outcome Management System (PCOMS)
Number of subjects: 1733
Study 34949156 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual (TAU)
Number of subjects: 1733
Study 34480858 — intervention group
Group type: EXPERIMENTAL
Intervention: Third dose of ChAdOx1 nCoV-19 (given 28-38 weeks after the second dose)
Number of subjects: 90
Study 34480858 — intervention group
Group type: EXPERIMENTAL
Intervention: Late second dose of ChAdOx1 nCoV-19 (given 44-45 weeks after the first dose)
Number of subjects: 90
Study 34480858 — intervention group
Group type: EXPERIMENTAL
Intervention: Single dose of ChAdOx1 nCoV-19
Number of subjects: 90
Study 34480858 — intervention group
Group type: EXPERIMENTAL
Intervention: Third dose of ChAdOx1 nCoV-19
Number of subjects: 90
Study 34480858 — intervention group
Group type: EXPERIMENTAL
Intervention: Late second dose of ChAdOx1 nCoV-19
Number of subjects: 90
Study 33262186 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-monitoring of blood pressure (SMBP)
Number of subjects: 147
Study 35724857 — intervention group
Group type: EXPERIMENTAL
Intervention: Low dose (3 mg/kg/day)
Number of subjects: 30
Study 35724857 — intervention group
Group type: EXPERIMENTAL
Intervention: High dose (10 mg/kg/day)
Number of subjects: 30
Study 35724857 — intervention group
Group type: COMPARATOR
Intervention: Control (distilled water)
Number of subjects: 30
Study 32767145 — intervention group
Group type: EXPERIMENTAL
Intervention: AirSeal® (group A)
Number of subjects: 198
Study 32767145 — intervention group
Group type: COMPARATOR
Intervention: Standard CO2 insufflator (group S)
Number of subjects: 198
Study 32650818 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydroxychloroquine (600 mg first dose, then 200 mg twice daily for 7 days, total 3 g)
Number of subjects: 120
Study 32650818 — intervention group
Group type: COMPARATOR
Intervention: Placebo (equivalent number of capsules to Hydroxychloroquine)
Number of subjects: 120
Study 35583585 — intervention group
Group type: EXPERIMENTAL
Intervention: Joint production pedagogy
Number of subjects: 59
Study 35583585 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 59
Study 33027166 — intervention group
Group type: EXPERIMENTAL
Intervention: Total hip arthroplasty
Number of subjects: 1441
Study 33027166 — intervention group
Group type: COMPARATOR
Intervention: Hemiarthroplasty
Number of subjects: 1441
Study 33345878 — intervention group
Group type: EXPERIMENTAL
Intervention: Breastfeeding Friend smartphone application
Number of subjects: 170
Study 33345878 — intervention group
Group type: COMPARATOR
Intervention: Control smartphone application
Number of subjects: 170
Study 33111563 — intervention group
Group type: EXPERIMENTAL
Intervention: Supported dynamic lumbar extension with the abdominal drawing‐in maneuver (ADIM) technique
Number of subjects: 30
Study 33111563 — intervention group
Group type: COMPARATOR
Intervention: Control-sitting without exercise
Number of subjects: 30
Study 35881180 — intervention group
Group type: EXPERIMENTAL
Intervention: Systemic treatment with sorafenib (either alone or combined with locoregional therapies)
Number of subjects: 67
Study 35881180 — intervention group
Group type: COMPARATOR
Intervention: Not applicable (control group not specified)
Number of subjects: 67
Study 33452438 — intervention group
Group type: EXPERIMENTAL
Intervention: Propranolol (40 mg)
Number of subjects: 90
Study 33452438 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 90
Study 32700596 — intervention group
Group type: EXPERIMENTAL
Intervention: 8 mm ultra-thin wall (UTW) staked needle syringe
Number of subjects: 0
Study 32700596 — intervention group
Group type: COMPARATOR
Intervention: 12.7 mm special-thin wall (STW) staked needle syringe
Number of subjects: 0
Study 35649613 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydroxychloroquine plus personal protective equipment
Number of subjects: 416
Study 35649613 — intervention group
Group type: COMPARATOR
Intervention: Personal protective equipment alone
Number of subjects: 416
Study 32078837 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Behavioural Therapy (CBT)
Number of subjects: 52
Study 32078837 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychoeducation (PE)
Number of subjects: 52
Study 32078837 — intervention group
Group type: COMPARATOR
Intervention: Treatment as Usual (TAU)
Number of subjects: 52
Study 35951124 — intervention group
Group type: EXPERIMENTAL
Intervention: Er:YAG laser (ERL) set at energy level of 100 mJ/pulse, frequency of 10 Hz, pulse duration of 100 µs, irradiated by three passages
Number of subjects: 23
Study 35951124 — intervention group
Group type: COMPARATOR
Intervention: Mechanical debridement using an ultrasonic scaler
Number of subjects: 23
Study 33283994 — intervention group
Group type: EXPERIMENTAL
Intervention: Severe SCFE
Number of subjects: 51
Study 33283994 — intervention group
Group type: EXPERIMENTAL
Intervention: Epiphyseal rotation
Number of subjects: 51
Study 34937222 — intervention group
Group type: EXPERIMENTAL
Intervention: SRK/T
Number of subjects: 164
Study 34937222 — intervention group
Group type: EXPERIMENTAL
Intervention: Holladay 2
Number of subjects: 164
Study 34937222 — intervention group
Group type: EXPERIMENTAL
Intervention: Barrett Universal II
Number of subjects: 164
Study 34937222 — intervention group
Group type: EXPERIMENTAL
Intervention: SRK II
Number of subjects: 164
Study 34937222 — intervention group
Group type: EXPERIMENTAL
Intervention: Hoffer Q
Number of subjects: 164
Study 32790575 — intervention group
Group type: EXPERIMENTAL
Intervention: Dynamic hamstring stretching with strengthening exercises
Number of subjects: 46
Study 32790575 — intervention group
Group type: COMPARATOR
Intervention: Static hamstring stretching with strengthening exercises
Number of subjects: 46
Study 33314461 — intervention group
Group type: EXPERIMENTAL
Intervention: Oil pulling (sunflower oil)
Number of subjects: 26
Study 33314461 — intervention group
Group type: COMPARATOR
Intervention: Mineral water
Number of subjects: 26
Study 33789555 — intervention group
Group type: EXPERIMENTAL
Intervention: Probiotic treatment (Limosilactobacillus fermentum LF16, Lacticaseibacillus rhamnosus LR06, Lactiplantibacillus plantarum LP01, Bifidobacterium longum 04)
Number of subjects: 33
Study 33789555 — intervention group
Group type: COMPARATOR
Intervention: Placebo treatment (maltodextrin)
Number of subjects: 33
Study 35271448 — intervention group
Group type: EXPERIMENTAL
Intervention: VIRTUE (immersive virtual reality application)
Number of subjects: 0
Study 35271448 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study 32474982 — intervention group
Group type: EXPERIMENTAL
Intervention: E2 (WB50 extended in a 2:1 ratio with milk-based extender)
Number of subjects: 15
Study 32474982 — intervention group
Group type: COMPARATOR
Intervention: Control (pure raw semen)
Number of subjects: 15
Study 32474982 — intervention group
Group type: EXPERIMENTAL
Intervention: E1 (WB50 extended in a 1:1 ratio with milk-based extender)
Number of subjects: 15
Study 32474982 — intervention group
Group type: EXPERIMENTAL
Intervention: WB50 (50% whole blood added into semen)
Number of subjects: 15
Study 34283851 — intervention group
Group type: EXPERIMENTAL
Intervention: Breakthrough series collaborative intervention including data collection, learning events, Plan-Study-Do-Act cycles, and teleconferences every 6 weeks.
Number of subjects: 586
Study 34283851 — intervention group
Group type: EXPERIMENTAL
Intervention: Breakthrough series collaborative intervention
Number of subjects: 586
Study 32506922 — intervention group
Group type: EXPERIMENTAL
Intervention: mHealth intervention (electronic medication tray and mHealth app)
Number of subjects: 80
Study 32506922 — intervention group
Group type: COMPARATOR
Intervention: Control arm
Number of subjects: 80
Study 36163020 — intervention group
Group type: EXPERIMENTAL
Intervention: Camostat mesilate (600 mg qid for up to 14 days)
Number of subjects: 155
Study 36163020 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 155
Study 34174325 — intervention group
Group type: EXPERIMENTAL
Intervention: Fragmented sleep
Number of subjects: 9
Study 34174325 — intervention group
Group type: COMPARATOR
Intervention: Uninterrupted sleep
Number of subjects: 9
Study 36194970 — intervention group
Group type: EXPERIMENTAL
Intervention: Teaching strategy combining the 5E learning model and self‐efficacy
Number of subjects: 58
Study 36194970 — intervention group
Group type: COMPARATOR
Intervention: Conventional teaching methods
Number of subjects: 58
Study 33611132 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy (CBT)
Number of subjects: 51
Study 33611132 — intervention group
Group type: EXPERIMENTAL
Intervention: Relaxation Training (RT)
Number of subjects: 51
Study 33611132 — intervention group
Group type: COMPARATOR
Intervention: Health Education (HE)
Number of subjects: 51
Study 33611132 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy (CBT) or Relaxation Training (RT)
Number of subjects: 51
Study 36054737 — intervention group
Group type: EXPERIMENTAL
Intervention: Mealtime ultra rapid lispro (URLi)
Number of subjects: 716
Study 36054737 — intervention group
Group type: EXPERIMENTAL
Intervention: Postmeal ultra rapid lispro (URLi)
Number of subjects: 716
Study 36054737 — intervention group
Group type: COMPARATOR
Intervention: Lispro
Number of subjects: 716
Study 33479721 — intervention group
Group type: EXPERIMENTAL
Intervention: 80-mg ixekizumab (IXE) every 2 weeks
Number of subjects: 363
Study 33479721 — intervention group
Group type: EXPERIMENTAL
Intervention: 80-mg ixekizumab (IXE) every 4 weeks
Number of subjects: 363
Study 33479721 — intervention group
Group type: COMPARATOR
Intervention: 80-mg ixekizumab (IXE)
Number of subjects: 363
Study 33479721 — intervention group
Group type: COMPARATOR
Intervention: Placebo (PBO)
Number of subjects: 363
Study 36169991 — intervention group
Group type: EXPERIMENTAL
Intervention: Calm app intervention
Number of subjects: 1029
Study 36169991 — intervention group
Group type: COMPARATOR
Intervention: Waitlist control
Number of subjects: 1029
Study 32840319 — intervention group
Group type: EXPERIMENTAL
Intervention: Expander with differential opening (EDO)
Number of subjects: 48
Study 32840319 — intervention group
Group type: COMPARATOR
Intervention: Fan-type expander (FE)
Number of subjects: 48
Study 33585991 — intervention group
Group type: EXPERIMENTAL
Intervention: Stent placement combined with intra‐RFA and HAIC
Number of subjects: 135